| Added by | standudu |
|---|---|
| Group name | EquipeCTCS |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Departement de Pharmacie Clinique, Institut regional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. Melodie.DellOva@chu-fortdefrance.fr. Medical Oncology Department, Institut Claudius Regaud, IUCT- Oncopole, Toulouse, France. DeMaio.Eleonora@iuct-oncopole.fr. Medical Oncology Department, Centre Georges-Francois Leclerc, Dijon, France. sguiu@cgfl.fr. Breast Center (CePO), University Hospital CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland. sguiu@cgfl.fr. Departement de Biostatistiques, Institut regional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. Lise.Roca@icm.unicancer.fr. Medical Oncology Department, Institut Claudius Regaud, IUCT- Oncopole, Toulouse, France. dalenc.florence@iuct-oncopole.fr. Departement d'Oncologie Medicale, Institut regional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. Anna.DurigovaAbdouh@hcuge.ch. Medical Oncology Department, University Hospital of Geneva, Gabrielle-Perret-Gentil 4, 1211, Geneva, Switzerland. Anna.DurigovaAbdouh@hcuge.ch. Departement de Pharmacie Clinique, Institut regional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. Frederic.Pinguet@icm.unicancer.fr. Departement de Pharmacie Clinique, Institut regional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. khedidja.Bekhtari@icm.unicancer.fr. Departement d'Oncologie Medicale, Institut regional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. William.jacot@icm.unicancer.fr. Departement d'Oncologie Medicale, Institut regional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. stephane.pouderoux@icm.unicancer.fr. alt-title: BMC cancer accession-num: 26449988 |
| Tags | _EndnoteXML import |
| Date Added | 2018/11/14 - 15:25:02 |
| Date Modified | 2018/11/14 - 15:25:02 |
| Parent item | Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study |
Institut de Recherche en Cancérologie de
